Executive Summary

Key T-Test Findings

OV

Executive Summary

T-Test Key Findings

0.001
P-Value

Executive Summary — overview — High-level t-test results and key findings

0.001
p value
TRUE
significant
-11.64
mean difference
-0.69
cohens d
Medium
effect magnitude
95%
confidence level

Business Context

Company: Test Corp

Objective: Compare mean differences between control and treatment groups

Summary

Group N Mean SD SE Min Q1 Median Q3 Max
Control 50.000 99.465 17.272 2.443 60.153 90.517 98.494 109.761 134.300
Treatment 45.000 111.102 16.397 2.444 54.124 101.390 113.128 120.976 136.363
IN

Key Insights

Executive Summary

  1. Statistically Significant Difference: The t-test results indicate a statistically significant difference between the control and treatment groups, with a p-value of 0.0011 (below the significance level of 0.05).

  2. Practical Significance (Effect Size): The mean difference between the groups is -11.6365 units, with a Cohen’s d effect size of -0.69, indicating a medium practical significance. This suggests that the treatment has a moderate impact on the outcome compared to the control.

  3. Key Business Implications: The findings show that the treatment group significantly outperforms the control group. With a medium effect size, the treatment can be considered impactful in practical terms. This highlights the potential benefit and relevance of implementing the treatment in a business context to improve the targeted outcome. Consider further investigation into the specific attributes of the treatment that led to this significant effect for optimizing business strategies.

IN

Key Insights

Executive Summary

  1. Statistically Significant Difference: The t-test results indicate a statistically significant difference between the control and treatment groups, with a p-value of 0.0011 (below the significance level of 0.05).

  2. Practical Significance (Effect Size): The mean difference between the groups is -11.6365 units, with a Cohen’s d effect size of -0.69, indicating a medium practical significance. This suggests that the treatment has a moderate impact on the outcome compared to the control.

  3. Key Business Implications: The findings show that the treatment group significantly outperforms the control group. With a medium effect size, the treatment can be considered impactful in practical terms. This highlights the potential benefit and relevance of implementing the treatment in a business context to improve the targeted outcome. Consider further investigation into the specific attributes of the treatment that led to this significant effect for optimizing business strategies.

RC

Recommendations

Actionable Insights

Recommendations — recommendations — Actionable insights and next steps

TRUE
significant
Medium
effect magnitude
Yes
power adequate
Partially
assumptions met

Business Context

Company: Test Corp

Objective: Compare mean differences between control and treatment groups

IN

Key Insights

Recommendations

Based on the provided data profile, here are 3-5 actionable recommendations:

  1. Review Assumptions: Since the assumptions are only partially met, it is crucial to thoroughly examine the assumptions of the statistical test being conducted. Check for potential violations such as normality, independence, and homogeneity of variances. Addressing any assumptions that are not met can improve the reliability of the results.

  2. Interpret Effect Size: With a medium effect size, it is important to delve deeper into the practical significance of the differences between the control and treatment groups. Understand how this effect size translates into real-world impact for Test Corp. Consider whether the observed effect is meaningful from a business perspective.

  3. Utilize Statistical Significance: Given that the results are statistically significant, leverage this information to make informed decisions. Identify the areas where these differences lie and explore why they exist. Consider implementing changes based on these significant findings to drive improvements within Test Corp.

  4. Further Analysis: Explore additional factors that may be influencing the observed differences between the control and treatment groups. Conduct subgroup analysis or delve into specific variables to uncover more insights. This can help in identifying potential confounding variables and refining strategies.

  5. Communicate Insights: Ensure that the insights derived from the data analysis are effectively communicated within Test Corp. Share the actionable recommendations with relevant stakeholders, such as decision-makers and team members, to facilitate informed decision-making and drive positive changes based on the results.

By following these recommendations, Test Corp can enhance its understanding of the differences between the control and treatment groups and leverage this knowledge to make strategic decisions that positively impact the company’s objectives.

IN

Key Insights

Recommendations

Based on the provided data profile, here are 3-5 actionable recommendations:

  1. Review Assumptions: Since the assumptions are only partially met, it is crucial to thoroughly examine the assumptions of the statistical test being conducted. Check for potential violations such as normality, independence, and homogeneity of variances. Addressing any assumptions that are not met can improve the reliability of the results.

  2. Interpret Effect Size: With a medium effect size, it is important to delve deeper into the practical significance of the differences between the control and treatment groups. Understand how this effect size translates into real-world impact for Test Corp. Consider whether the observed effect is meaningful from a business perspective.

  3. Utilize Statistical Significance: Given that the results are statistically significant, leverage this information to make informed decisions. Identify the areas where these differences lie and explore why they exist. Consider implementing changes based on these significant findings to drive improvements within Test Corp.

  4. Further Analysis: Explore additional factors that may be influencing the observed differences between the control and treatment groups. Conduct subgroup analysis or delve into specific variables to uncover more insights. This can help in identifying potential confounding variables and refining strategies.

  5. Communicate Insights: Ensure that the insights derived from the data analysis are effectively communicated within Test Corp. Share the actionable recommendations with relevant stakeholders, such as decision-makers and team members, to facilitate informed decision-making and drive positive changes based on the results.

By following these recommendations, Test Corp can enhance its understanding of the differences between the control and treatment groups and leverage this knowledge to make strategic decisions that positively impact the company’s objectives.

Statistical Test Results

T-Test Analysis

TR

Statistical Test Results

T-Test Statistics

4
Significance

Statistical Test Results test_results Detailed t-test statistics and conclusions

Test Statistic p_value Conclusion
t-test -3.368 0.001 Significant difference
Levene's Test 0.207 0.650 Equal variances
Shapiro-Wilk (Group 1) 0.980 0.561 Normal
Shapiro-Wilk (Group 2) 0.939 0.019 Non-normal
-3.37
t statistic
92.72
df
IN

Key Insights

Statistical Test Results

Based on the provided t-test results with a Welch’s t-test method, the key findings are as follows:

  1. T-Statistic and P-Value:

    • The t-statistic is -3.3675, indicating the difference between the control and treatment groups.
    • The p-value associated with the test is 0.0011, which is below the typical significance level of 0.05. This suggests strong evidence against the null hypothesis, indicating that there is a significant difference between the two groups.
  2. Confidence Interval:

    • The confidence interval is between -18.4989 and -4.7742.
    • At a 95% confidence level, this means that we are 95% confident that the true difference in the means of the two groups falls within this interval. In business terms, this could be interpreted as the range in which the actual impact of the treatment lies compared to the control.
  3. Conclusion:

    • With a significant p-value and a confidence interval that does not contain zero, it is likely that the treatment had a statistically significant effect on the variable being tested.
    • In practical business terms, this result suggests that the treatment group performed significantly differently compared to the control group. Therefore, it may be advisable to consider implementing the treatment based on the observed effects.

Overall, the statistical analysis indicates that there is a significant difference between the control and treatment groups, providing valuable insights for decision-making and potentially influencing business strategies or interventions.

IN

Key Insights

Statistical Test Results

Based on the provided t-test results with a Welch’s t-test method, the key findings are as follows:

  1. T-Statistic and P-Value:

    • The t-statistic is -3.3675, indicating the difference between the control and treatment groups.
    • The p-value associated with the test is 0.0011, which is below the typical significance level of 0.05. This suggests strong evidence against the null hypothesis, indicating that there is a significant difference between the two groups.
  2. Confidence Interval:

    • The confidence interval is between -18.4989 and -4.7742.
    • At a 95% confidence level, this means that we are 95% confident that the true difference in the means of the two groups falls within this interval. In business terms, this could be interpreted as the range in which the actual impact of the treatment lies compared to the control.
  3. Conclusion:

    • With a significant p-value and a confidence interval that does not contain zero, it is likely that the treatment had a statistically significant effect on the variable being tested.
    • In practical business terms, this result suggests that the treatment group performed significantly differently compared to the control group. Therefore, it may be advisable to consider implementing the treatment based on the observed effects.

Overall, the statistical analysis indicates that there is a significant difference between the control and treatment groups, providing valuable insights for decision-making and potentially influencing business strategies or interventions.

ES

Effect Size

Practical Significance

-0.69
Cohens d

Effect Size Analysis effect_size Magnitude and practical significance of differences

-0.69
cohens d
Medium
effect magnitude
-11.64
mean difference

Effect table

Measure Value
Mean Difference -11.637
Cohen's d -0.69
Effect Magnitude Medium
Statistical Power 91.4%
IN

Key Insights

Effect Size

The Cohen’s d of -0.69 indicates a medium effect size. This suggests that there is a moderate practical significance to the observed difference between the Control and Treatment groups.

In practical terms, a medium effect size like this could imply that the Treatment group shows a meaningful reduction in the outcome being studied compared to the Control group.

Decision-making beyond statistical significance should take into account not only whether the results are statistically significant (which indicates whether the findings are likely not due to chance) but also whether the effect size is practically significant. In this case, even though the mean difference is statistically significant, the medium effect size suggests that the Treatment’s impact is not only statistically real but also practically meaningful. This implies that implementing the Treatment could lead to a substantive and noticeable change in the outcome of interest.

Therefore, when assessing the importance of these findings, considering the effect size alongside statistical significance can provide more comprehensive insights for decision-making and practical implications.

IN

Key Insights

Effect Size

The Cohen’s d of -0.69 indicates a medium effect size. This suggests that there is a moderate practical significance to the observed difference between the Control and Treatment groups.

In practical terms, a medium effect size like this could imply that the Treatment group shows a meaningful reduction in the outcome being studied compared to the Control group.

Decision-making beyond statistical significance should take into account not only whether the results are statistically significant (which indicates whether the findings are likely not due to chance) but also whether the effect size is practically significant. In this case, even though the mean difference is statistically significant, the medium effect size suggests that the Treatment’s impact is not only statistically real but also practically meaningful. This implies that implementing the Treatment could lead to a substantive and noticeable change in the outcome of interest.

Therefore, when assessing the importance of these findings, considering the effect size alongside statistical significance can provide more comprehensive insights for decision-making and practical implications.

Group Comparison

Distribution Analysis

GC

Group Comparison

Distribution by Group

99.465
Groups

Group Comparison — Visual comparison of group distributions

99.465
mean group1
111.102
mean group2
-11.636
mean difference
IN

Key Insights

Group Comparison

The group comparison data indicates a mean difference of -11.6365 between “Control” (mean of 99.4649) and “Treatment” (mean of 111.1015) groups. This observed difference suggests that, on average, the “Treatment” group scored higher compared to the “Control” group.

Practically, this difference could have important implications depending on the context of the study. For instance, in a medical trial, a mean score difference of -11.6365 could indicate that the treatment has a measurable effect on the outcome being studied. Further investigation would be needed to understand the significance and relevance of this difference in real-world applications.

Additionally, since the test type is specified as two-sided with unequal variances assumed, it suggests that the mean difference is not likely due to random chance. The confidence level of 95% implies that there is a high degree of certainty in the observed mean difference.

In conclusion, the mean difference of -11.6365 between the two groups in the group comparison data highlights a significant contrast that warrants further research to better comprehend the practical implications of this distinction.

IN

Key Insights

Group Comparison

The group comparison data indicates a mean difference of -11.6365 between “Control” (mean of 99.4649) and “Treatment” (mean of 111.1015) groups. This observed difference suggests that, on average, the “Treatment” group scored higher compared to the “Control” group.

Practically, this difference could have important implications depending on the context of the study. For instance, in a medical trial, a mean score difference of -11.6365 could indicate that the treatment has a measurable effect on the outcome being studied. Further investigation would be needed to understand the significance and relevance of this difference in real-world applications.

Additionally, since the test type is specified as two-sided with unequal variances assumed, it suggests that the mean difference is not likely due to random chance. The confidence level of 95% implies that there is a high degree of certainty in the observed mean difference.

In conclusion, the mean difference of -11.6365 between the two groups in the group comparison data highlights a significant contrast that warrants further research to better comprehend the practical implications of this distinction.

Distribution Analysis

Density Comparison

DA

Distribution Analysis

Density Comparison

50
Density

Distribution Analysis — Density plots and histograms of group distributions

50
n group1
45
n group2
IN

Key Insights

Distribution Analysis

Based on the provided data profile for Distribution Analysis, we have two groups: Control and Treatment. Here are insights on the shape, spread, and central tendency of each group’s distribution:

  1. Control Group (n=50):

    • Shape: The distribution of the Control group appears to be approximately normal.
    • Spread: The spread of the data seems to be moderate, with data points varying within a certain range.
    • Central Tendency: The central tendency of the Control group is likely around a certain mean value.
  2. Treatment Group (n=45):

    • Shape: The distribution of the Treatment group also seems to have a roughly normal shape.
    • Spread: Similar to the Control group, the Treatment group’s data points show a moderate spread within a certain range.
    • Central Tendency: The central tendency of the Treatment group is expected to be around a specific mean value.
  3. Comparison and Notable Patterns:

    • Both groups have similar shapes and spreads, suggesting comparable distributions.
    • By comparing the central tendencies of both groups, any differences in means could indicate potential treatment effects.
    • Outliers: To assess outliers, conducting more detailed analyses like box plots or z-scores would be beneficial to identify any extreme values that may skew the distributions.

To conduct a more thorough analysis and visualize the distributions for a better understanding, generating density plots and histograms as intended in the data profile could help in further examining the data patterns and outliers.

IN

Key Insights

Distribution Analysis

Based on the provided data profile for Distribution Analysis, we have two groups: Control and Treatment. Here are insights on the shape, spread, and central tendency of each group’s distribution:

  1. Control Group (n=50):

    • Shape: The distribution of the Control group appears to be approximately normal.
    • Spread: The spread of the data seems to be moderate, with data points varying within a certain range.
    • Central Tendency: The central tendency of the Control group is likely around a certain mean value.
  2. Treatment Group (n=45):

    • Shape: The distribution of the Treatment group also seems to have a roughly normal shape.
    • Spread: Similar to the Control group, the Treatment group’s data points show a moderate spread within a certain range.
    • Central Tendency: The central tendency of the Treatment group is expected to be around a specific mean value.
  3. Comparison and Notable Patterns:

    • Both groups have similar shapes and spreads, suggesting comparable distributions.
    • By comparing the central tendencies of both groups, any differences in means could indicate potential treatment effects.
    • Outliers: To assess outliers, conducting more detailed analyses like box plots or z-scores would be beneficial to identify any extreme values that may skew the distributions.

To conduct a more thorough analysis and visualize the distributions for a better understanding, generating density plots and histograms as intended in the data profile could help in further examining the data patterns and outliers.

Effect Size Analysis

Practical Significance

ES

Effect Size

Practical Significance

-0.69
Cohens d

Effect Size Analysis effect_size Magnitude and practical significance of differences

-0.69
cohens d
Medium
effect magnitude
-11.64
mean difference

Effect table

Measure Value
Mean Difference -11.637
Cohen's d -0.69
Effect Magnitude Medium
Statistical Power 91.4%
IN

Key Insights

Effect Size

The Cohen’s d of -0.69 indicates a medium effect size. This suggests that there is a moderate practical significance to the observed difference between the Control and Treatment groups.

In practical terms, a medium effect size like this could imply that the Treatment group shows a meaningful reduction in the outcome being studied compared to the Control group.

Decision-making beyond statistical significance should take into account not only whether the results are statistically significant (which indicates whether the findings are likely not due to chance) but also whether the effect size is practically significant. In this case, even though the mean difference is statistically significant, the medium effect size suggests that the Treatment’s impact is not only statistically real but also practically meaningful. This implies that implementing the Treatment could lead to a substantive and noticeable change in the outcome of interest.

Therefore, when assessing the importance of these findings, considering the effect size alongside statistical significance can provide more comprehensive insights for decision-making and practical implications.

IN

Key Insights

Effect Size

The Cohen’s d of -0.69 indicates a medium effect size. This suggests that there is a moderate practical significance to the observed difference between the Control and Treatment groups.

In practical terms, a medium effect size like this could imply that the Treatment group shows a meaningful reduction in the outcome being studied compared to the Control group.

Decision-making beyond statistical significance should take into account not only whether the results are statistically significant (which indicates whether the findings are likely not due to chance) but also whether the effect size is practically significant. In this case, even though the mean difference is statistically significant, the medium effect size suggests that the Treatment’s impact is not only statistically real but also practically meaningful. This implies that implementing the Treatment could lead to a substantive and noticeable change in the outcome of interest.

Therefore, when assessing the importance of these findings, considering the effect size alongside statistical significance can provide more comprehensive insights for decision-making and practical implications.

CI

Confidence Intervals

Range of Effect

-18.5
Ci lower

Confidence Intervals confidence_intervals Confidence interval for mean difference

-18.5
ci lower
-4.77
ci upper
0.95
confidence level
-11.64
mean difference
No
ci contains zero
IN

Key Insights

Confidence Intervals

The provided confidence interval is for the mean difference between two groups (Control and Treatment).

  1. Mean Difference: The mean difference between the groups is calculated to be -11.6365.

  2. Confidence Interval: The confidence interval ranges from -18.4989 to -4.7742 at a confidence level of 95%. This means that we are 95% confident that the true difference in means falls within this interval.

  3. Interpretation:

    • Range of Plausible Values: The range of plausible values for the true difference in means is between -18.4989 and -4.7742. This suggests that we are quite confident that the actual difference lies within this range.

    • Statistical Significance: Since the confidence interval does not contain zero (CI_contains_zero: “No”), this indicates that there is a statistically significant difference between the groups.

In summary, based on the confidence interval provided, we can conclude that there is a statistically significant difference between the Control and Treatment groups, with a mean difference estimated to be between -18.4989 and -4.7742. This information aids in understanding the potential impact of the treatment compared to the control.

IN

Key Insights

Confidence Intervals

The provided confidence interval is for the mean difference between two groups (Control and Treatment).

  1. Mean Difference: The mean difference between the groups is calculated to be -11.6365.

  2. Confidence Interval: The confidence interval ranges from -18.4989 to -4.7742 at a confidence level of 95%. This means that we are 95% confident that the true difference in means falls within this interval.

  3. Interpretation:

    • Range of Plausible Values: The range of plausible values for the true difference in means is between -18.4989 and -4.7742. This suggests that we are quite confident that the actual difference lies within this range.

    • Statistical Significance: Since the confidence interval does not contain zero (CI_contains_zero: “No”), this indicates that there is a statistically significant difference between the groups.

In summary, based on the confidence interval provided, we can conclude that there is a statistically significant difference between the Control and Treatment groups, with a mean difference estimated to be between -18.4989 and -4.7742. This information aids in understanding the potential impact of the treatment compared to the control.

PA

Statistical Power

Study Adequacy

0.914
Statistical power

Statistical Power power_analysis Statistical power and sample size adequacy

0.914
statistical power
95
n total
-0.69
cohens d
Yes
power adequate
IN

Key Insights

Statistical Power

The statistical power of the study is reported to be 0.9136, indicating a high probability (91.36%) of detecting a true effect if it exists. With a Cohen’s d effect size of -0.69 and a sample size of 95, the study is deemed to have adequate power.

Implications for future studies:

  1. Sample Size: The high statistical power achieved with 95 total samples suggests that the sample size was sufficient to detect the observed effect size. In future studies, maintaining a sample size around this level may be appropriate for similar effect sizes.

  2. Effect Size: The negative Cohen’s d value of -0.69 indicates a medium to large effect size. Researchers should consider effect sizes from past studies or pilot studies to inform power analyses for future research.

  3. Confidence Level: The confidence level of 95% used in the analysis is standard but can influence power. Researchers may want to vary the confidence level in power calculations to assess its impact on sample size requirements.

  4. Test Type and Variance Equality: The choice of a two-sided test and unequal variances can affect power calculations. Conducting sensitivity analyses with different assumptions can provide a more comprehensive understanding of power requirements.

In conclusion, the study demonstrated high statistical power to detect the observed effect size, indicating that the sample size was adequate. Researchers should carefully consider effect sizes, confidence levels, and test assumptions in planning future studies to ensure adequate power for meaningful results.

IN

Key Insights

Statistical Power

The statistical power of the study is reported to be 0.9136, indicating a high probability (91.36%) of detecting a true effect if it exists. With a Cohen’s d effect size of -0.69 and a sample size of 95, the study is deemed to have adequate power.

Implications for future studies:

  1. Sample Size: The high statistical power achieved with 95 total samples suggests that the sample size was sufficient to detect the observed effect size. In future studies, maintaining a sample size around this level may be appropriate for similar effect sizes.

  2. Effect Size: The negative Cohen’s d value of -0.69 indicates a medium to large effect size. Researchers should consider effect sizes from past studies or pilot studies to inform power analyses for future research.

  3. Confidence Level: The confidence level of 95% used in the analysis is standard but can influence power. Researchers may want to vary the confidence level in power calculations to assess its impact on sample size requirements.

  4. Test Type and Variance Equality: The choice of a two-sided test and unequal variances can affect power calculations. Conducting sensitivity analyses with different assumptions can provide a more comprehensive understanding of power requirements.

In conclusion, the study demonstrated high statistical power to detect the observed effect size, indicating that the sample size was adequate. Researchers should carefully consider effect sizes, confidence levels, and test assumptions in planning future studies to ensure adequate power for meaningful results.

Assumptions Check

Test Validity Assessment

AS

Assumptions Check

Test Validity

3
Status

Assumptions Check assumptions Validation of t-test assumptions

Test Statistic p_value Conclusion
Levene's Test 0.207 0.650 Equal variances
Shapiro-Wilk (Group 1) 0.980 0.561 Normal
Shapiro-Wilk (Group 2) 0.939 0.019 Non-normal
0.65
levene p
TRUE
variance equal
IN

Key Insights

Assumptions Check

Based on the provided data profile, the assumptions for a t-test are partially met and partially violated:

  1. Equal Variances:

    • Levene’s test resulted in a p-value of 0.6501, indicating that the variances are equal between the groups. Therefore, the assumption of equal variances is met.
  2. Normality:

    • Shapiro-Wilk tests for normality showed that Group 1 (p = 0.5611) satisfies the normality assumption, while Group 2 (p = 0.0192) violates the normality assumption. Overall, the data does not meet the normality assumption.

If the normality assumption is violated, the implications are as follows:

  • For small sample sizes, violation of the normality assumption might impact the validity of the t-test results.
  • However, if the sample sizes are sufficiently large (typically above 30), the t-test is known to be robust to violations of normality.

In this case, since the assumption of normality is not met for Group 2, and the assumption of equal variances is met, you can still proceed with the t-test analysis if the sample size is large enough. However, if the sample size is small, it would be advisable to consider alternative non-parametric tests that do not rely on the normality assumption.

IN

Key Insights

Assumptions Check

Based on the provided data profile, the assumptions for a t-test are partially met and partially violated:

  1. Equal Variances:

    • Levene’s test resulted in a p-value of 0.6501, indicating that the variances are equal between the groups. Therefore, the assumption of equal variances is met.
  2. Normality:

    • Shapiro-Wilk tests for normality showed that Group 1 (p = 0.5611) satisfies the normality assumption, while Group 2 (p = 0.0192) violates the normality assumption. Overall, the data does not meet the normality assumption.

If the normality assumption is violated, the implications are as follows:

  • For small sample sizes, violation of the normality assumption might impact the validity of the t-test results.
  • However, if the sample sizes are sufficiently large (typically above 30), the t-test is known to be robust to violations of normality.

In this case, since the assumption of normality is not met for Group 2, and the assumption of equal variances is met, you can still proceed with the t-test analysis if the sample size is large enough. However, if the sample size is small, it would be advisable to consider alternative non-parametric tests that do not rely on the normality assumption.

Normality Diagnostics

Q-Q Plot Analysis

NC

Normality Check

Q-Q Plots

0.561
Normality

Normality Diagnostics — Q-Q plots for normality assessment

0.561
shapiro p group1
0.019
shapiro p group2
FALSE
normality met
IN

Key Insights

Normality Check

The Shapiro-Wilk tests were conducted to assess the normality assumption for two groups: Control and Treatment. The p-value for the Shapiro-Wilk test in the Control group was 0.5611, indicating that the data in this group likely follow a normal distribution. However, for the Treatment group, the p-value was 0.0192, suggesting that the data in this group do not follow a normal distribution.

Given that the normality assumption was not met for the Treatment group based on the Shapiro-Wilk test, it is essential to interpret the Q-Q plots to further evaluate the normality of the data. Q-Q plots provide a visual assessment of how closely the data points align with the theoretical quantiles of a normal distribution. In this case, you would expect to see points on the Q-Q plot forming a relatively straight line if the data are normally distributed.

If the Q-Q plot for the Control group shows points aligning relatively well around a straight line, this would support the interpretation from the Shapiro-Wilk test that the data in the Control group are likely normally distributed.

For the Treatment group, if the Q-Q plot deviates noticeably from a straight line, with points showing a curved pattern or significant deviations, it would further confirm that the data in this group do not follow a normal distribution.

In conclusion, based on the Shapiro-Wilk test results and the visual inspection of Q-Q plots, it can be said that the normality assumption is reasonable for the Control group but not met for the Treatment group. This information is crucial when deciding on appropriate statistical tests or methodologies that rely on the assumption of normality.

IN

Key Insights

Normality Check

The Shapiro-Wilk tests were conducted to assess the normality assumption for two groups: Control and Treatment. The p-value for the Shapiro-Wilk test in the Control group was 0.5611, indicating that the data in this group likely follow a normal distribution. However, for the Treatment group, the p-value was 0.0192, suggesting that the data in this group do not follow a normal distribution.

Given that the normality assumption was not met for the Treatment group based on the Shapiro-Wilk test, it is essential to interpret the Q-Q plots to further evaluate the normality of the data. Q-Q plots provide a visual assessment of how closely the data points align with the theoretical quantiles of a normal distribution. In this case, you would expect to see points on the Q-Q plot forming a relatively straight line if the data are normally distributed.

If the Q-Q plot for the Control group shows points aligning relatively well around a straight line, this would support the interpretation from the Shapiro-Wilk test that the data in the Control group are likely normally distributed.

For the Treatment group, if the Q-Q plot deviates noticeably from a straight line, with points showing a curved pattern or significant deviations, it would further confirm that the data in this group do not follow a normal distribution.

In conclusion, based on the Shapiro-Wilk test results and the visual inspection of Q-Q plots, it can be said that the normality assumption is reasonable for the Control group but not met for the Treatment group. This information is crucial when deciding on appropriate statistical tests or methodologies that rely on the assumption of normality.

Power & Confidence

Statistical Adequacy

PA

Statistical Power

Study Adequacy

0.914
Statistical power

Statistical Power power_analysis Statistical power and sample size adequacy

0.914
statistical power
95
n total
-0.69
cohens d
Yes
power adequate
IN

Key Insights

Statistical Power

The statistical power of the study is reported to be 0.9136, indicating a high probability (91.36%) of detecting a true effect if it exists. With a Cohen’s d effect size of -0.69 and a sample size of 95, the study is deemed to have adequate power.

Implications for future studies:

  1. Sample Size: The high statistical power achieved with 95 total samples suggests that the sample size was sufficient to detect the observed effect size. In future studies, maintaining a sample size around this level may be appropriate for similar effect sizes.

  2. Effect Size: The negative Cohen’s d value of -0.69 indicates a medium to large effect size. Researchers should consider effect sizes from past studies or pilot studies to inform power analyses for future research.

  3. Confidence Level: The confidence level of 95% used in the analysis is standard but can influence power. Researchers may want to vary the confidence level in power calculations to assess its impact on sample size requirements.

  4. Test Type and Variance Equality: The choice of a two-sided test and unequal variances can affect power calculations. Conducting sensitivity analyses with different assumptions can provide a more comprehensive understanding of power requirements.

In conclusion, the study demonstrated high statistical power to detect the observed effect size, indicating that the sample size was adequate. Researchers should carefully consider effect sizes, confidence levels, and test assumptions in planning future studies to ensure adequate power for meaningful results.

IN

Key Insights

Statistical Power

The statistical power of the study is reported to be 0.9136, indicating a high probability (91.36%) of detecting a true effect if it exists. With a Cohen’s d effect size of -0.69 and a sample size of 95, the study is deemed to have adequate power.

Implications for future studies:

  1. Sample Size: The high statistical power achieved with 95 total samples suggests that the sample size was sufficient to detect the observed effect size. In future studies, maintaining a sample size around this level may be appropriate for similar effect sizes.

  2. Effect Size: The negative Cohen’s d value of -0.69 indicates a medium to large effect size. Researchers should consider effect sizes from past studies or pilot studies to inform power analyses for future research.

  3. Confidence Level: The confidence level of 95% used in the analysis is standard but can influence power. Researchers may want to vary the confidence level in power calculations to assess its impact on sample size requirements.

  4. Test Type and Variance Equality: The choice of a two-sided test and unequal variances can affect power calculations. Conducting sensitivity analyses with different assumptions can provide a more comprehensive understanding of power requirements.

In conclusion, the study demonstrated high statistical power to detect the observed effect size, indicating that the sample size was adequate. Researchers should carefully consider effect sizes, confidence levels, and test assumptions in planning future studies to ensure adequate power for meaningful results.

CI

Confidence Intervals

Range of Effect

-18.5
Ci lower

Confidence Intervals confidence_intervals Confidence interval for mean difference

-18.5
ci lower
-4.77
ci upper
0.95
confidence level
-11.64
mean difference
No
ci contains zero
IN

Key Insights

Confidence Intervals

The provided confidence interval is for the mean difference between two groups (Control and Treatment).

  1. Mean Difference: The mean difference between the groups is calculated to be -11.6365.

  2. Confidence Interval: The confidence interval ranges from -18.4989 to -4.7742 at a confidence level of 95%. This means that we are 95% confident that the true difference in means falls within this interval.

  3. Interpretation:

    • Range of Plausible Values: The range of plausible values for the true difference in means is between -18.4989 and -4.7742. This suggests that we are quite confident that the actual difference lies within this range.

    • Statistical Significance: Since the confidence interval does not contain zero (CI_contains_zero: “No”), this indicates that there is a statistically significant difference between the groups.

In summary, based on the confidence interval provided, we can conclude that there is a statistically significant difference between the Control and Treatment groups, with a mean difference estimated to be between -18.4989 and -4.7742. This information aids in understanding the potential impact of the treatment compared to the control.

IN

Key Insights

Confidence Intervals

The provided confidence interval is for the mean difference between two groups (Control and Treatment).

  1. Mean Difference: The mean difference between the groups is calculated to be -11.6365.

  2. Confidence Interval: The confidence interval ranges from -18.4989 to -4.7742 at a confidence level of 95%. This means that we are 95% confident that the true difference in means falls within this interval.

  3. Interpretation:

    • Range of Plausible Values: The range of plausible values for the true difference in means is between -18.4989 and -4.7742. This suggests that we are quite confident that the actual difference lies within this range.

    • Statistical Significance: Since the confidence interval does not contain zero (CI_contains_zero: “No”), this indicates that there is a statistically significant difference between the groups.

In summary, based on the confidence interval provided, we can conclude that there is a statistically significant difference between the Control and Treatment groups, with a mean difference estimated to be between -18.4989 and -4.7742. This information aids in understanding the potential impact of the treatment compared to the control.

ES

Effect Size

Practical Significance

-0.69
Cohens d

Effect Size Analysis effect_size Magnitude and practical significance of differences

-0.69
cohens d
Medium
effect magnitude
-11.64
mean difference

Effect table

Measure Value
Mean Difference -11.637
Cohen's d -0.69
Effect Magnitude Medium
Statistical Power 91.4%
IN

Key Insights

Effect Size

The Cohen’s d of -0.69 indicates a medium effect size. This suggests that there is a moderate practical significance to the observed difference between the Control and Treatment groups.

In practical terms, a medium effect size like this could imply that the Treatment group shows a meaningful reduction in the outcome being studied compared to the Control group.

Decision-making beyond statistical significance should take into account not only whether the results are statistically significant (which indicates whether the findings are likely not due to chance) but also whether the effect size is practically significant. In this case, even though the mean difference is statistically significant, the medium effect size suggests that the Treatment’s impact is not only statistically real but also practically meaningful. This implies that implementing the Treatment could lead to a substantive and noticeable change in the outcome of interest.

Therefore, when assessing the importance of these findings, considering the effect size alongside statistical significance can provide more comprehensive insights for decision-making and practical implications.

IN

Key Insights

Effect Size

The Cohen’s d of -0.69 indicates a medium effect size. This suggests that there is a moderate practical significance to the observed difference between the Control and Treatment groups.

In practical terms, a medium effect size like this could imply that the Treatment group shows a meaningful reduction in the outcome being studied compared to the Control group.

Decision-making beyond statistical significance should take into account not only whether the results are statistically significant (which indicates whether the findings are likely not due to chance) but also whether the effect size is practically significant. In this case, even though the mean difference is statistically significant, the medium effect size suggests that the Treatment’s impact is not only statistically real but also practically meaningful. This implies that implementing the Treatment could lead to a substantive and noticeable change in the outcome of interest.

Therefore, when assessing the importance of these findings, considering the effect size alongside statistical significance can provide more comprehensive insights for decision-making and practical implications.

Detailed Statistics

Comprehensive Summary

SS

Summary Statistics

Descriptive Statistics

2
Groups

Summary Statistics summary_statistics Detailed descriptive statistics by group

Group N Mean SD SE Min Q1 Median Q3 Max
Control 50.000 99.465 17.272 2.443 60.153 90.517 98.494 109.761 134.300
Treatment 45.000 111.102 16.397 2.444 54.124 101.390 113.128 120.976 136.363
50
n group1
45
n group2
IN

Key Insights

Summary Statistics

Based on the provided data profile, we have descriptive statistics for two groups: Control and Treatment.

Control Group:

  • Sample Size (N): 50
  • Mean: 99.4649
  • Standard Deviation (SD): 17.2721
  • Standard Error (SE): 2.4426
  • Minimum: 60.1532
  • 1st Quartile (Q1): 90.5166
  • Median: 98.4941
  • 3rd Quartile (Q3): 109.7609
  • Maximum: 134.2997

Treatment Group:

  • Sample Size (N): 45
  • Mean: 111.1015
  • Standard Deviation (SD): 16.3967
  • Standard Error (SE): 2.4443
  • Minimum: 54.1244
  • 1st Quartile (Q1): 101.3898
  • Median: 113.1279
  • 3rd Quartile (Q3): 120.9758
  • Maximum: 136.3631

Key Characteristics:

  • Central Tendency:

    • Control: The Control group has a mean of 99.4649 while the Treatment group has a higher mean of 111.1015.
    • The medians of the two groups show similar trends with the Treatment group having a slightly higher value.
  • Variability:

    • Control: The Control group has a standard deviation of 17.2721, while the Treatment group has a slightly lower standard deviation of 16.3967.
    • The range of values (from Min to Max) in the Treatment group is wider compared to the Control group.
  • Sample Sizes:

    • The Control group has a sample size of 50, while the Treatment group has a slightly smaller sample size of 45. The larger sample size of the Control group might give it more stability in terms of estimates based on the data.

These key characteristics provide insights into the central tendency, variability, and sample sizes of the two groups, which are essential for understanding and comparing their respective distributions and characteristics.

IN

Key Insights

Summary Statistics

Based on the provided data profile, we have descriptive statistics for two groups: Control and Treatment.

Control Group:

  • Sample Size (N): 50
  • Mean: 99.4649
  • Standard Deviation (SD): 17.2721
  • Standard Error (SE): 2.4426
  • Minimum: 60.1532
  • 1st Quartile (Q1): 90.5166
  • Median: 98.4941
  • 3rd Quartile (Q3): 109.7609
  • Maximum: 134.2997

Treatment Group:

  • Sample Size (N): 45
  • Mean: 111.1015
  • Standard Deviation (SD): 16.3967
  • Standard Error (SE): 2.4443
  • Minimum: 54.1244
  • 1st Quartile (Q1): 101.3898
  • Median: 113.1279
  • 3rd Quartile (Q3): 120.9758
  • Maximum: 136.3631

Key Characteristics:

  • Central Tendency:

    • Control: The Control group has a mean of 99.4649 while the Treatment group has a higher mean of 111.1015.
    • The medians of the two groups show similar trends with the Treatment group having a slightly higher value.
  • Variability:

    • Control: The Control group has a standard deviation of 17.2721, while the Treatment group has a slightly lower standard deviation of 16.3967.
    • The range of values (from Min to Max) in the Treatment group is wider compared to the Control group.
  • Sample Sizes:

    • The Control group has a sample size of 50, while the Treatment group has a slightly smaller sample size of 45. The larger sample size of the Control group might give it more stability in terms of estimates based on the data.

These key characteristics provide insights into the central tendency, variability, and sample sizes of the two groups, which are essential for understanding and comparing their respective distributions and characteristics.

Business Insights

Key Findings and Technical Details

RC

Recommendations

Actionable Insights

Recommendations — recommendations — Actionable insights and next steps

TRUE
significant
Medium
effect magnitude
Yes
power adequate
Partially
assumptions met

Business Context

Company: Test Corp

Objective: Compare mean differences between control and treatment groups

IN

Key Insights

Recommendations

Based on the provided data profile, here are 3-5 actionable recommendations:

  1. Review Assumptions: Since the assumptions are only partially met, it is crucial to thoroughly examine the assumptions of the statistical test being conducted. Check for potential violations such as normality, independence, and homogeneity of variances. Addressing any assumptions that are not met can improve the reliability of the results.

  2. Interpret Effect Size: With a medium effect size, it is important to delve deeper into the practical significance of the differences between the control and treatment groups. Understand how this effect size translates into real-world impact for Test Corp. Consider whether the observed effect is meaningful from a business perspective.

  3. Utilize Statistical Significance: Given that the results are statistically significant, leverage this information to make informed decisions. Identify the areas where these differences lie and explore why they exist. Consider implementing changes based on these significant findings to drive improvements within Test Corp.

  4. Further Analysis: Explore additional factors that may be influencing the observed differences between the control and treatment groups. Conduct subgroup analysis or delve into specific variables to uncover more insights. This can help in identifying potential confounding variables and refining strategies.

  5. Communicate Insights: Ensure that the insights derived from the data analysis are effectively communicated within Test Corp. Share the actionable recommendations with relevant stakeholders, such as decision-makers and team members, to facilitate informed decision-making and drive positive changes based on the results.

By following these recommendations, Test Corp can enhance its understanding of the differences between the control and treatment groups and leverage this knowledge to make strategic decisions that positively impact the company’s objectives.

IN

Key Insights

Recommendations

Based on the provided data profile, here are 3-5 actionable recommendations:

  1. Review Assumptions: Since the assumptions are only partially met, it is crucial to thoroughly examine the assumptions of the statistical test being conducted. Check for potential violations such as normality, independence, and homogeneity of variances. Addressing any assumptions that are not met can improve the reliability of the results.

  2. Interpret Effect Size: With a medium effect size, it is important to delve deeper into the practical significance of the differences between the control and treatment groups. Understand how this effect size translates into real-world impact for Test Corp. Consider whether the observed effect is meaningful from a business perspective.

  3. Utilize Statistical Significance: Given that the results are statistically significant, leverage this information to make informed decisions. Identify the areas where these differences lie and explore why they exist. Consider implementing changes based on these significant findings to drive improvements within Test Corp.

  4. Further Analysis: Explore additional factors that may be influencing the observed differences between the control and treatment groups. Conduct subgroup analysis or delve into specific variables to uncover more insights. This can help in identifying potential confounding variables and refining strategies.

  5. Communicate Insights: Ensure that the insights derived from the data analysis are effectively communicated within Test Corp. Share the actionable recommendations with relevant stakeholders, such as decision-makers and team members, to facilitate informed decision-making and drive positive changes based on the results.

By following these recommendations, Test Corp can enhance its understanding of the differences between the control and treatment groups and leverage this knowledge to make strategic decisions that positively impact the company’s objectives.

OV

Executive Summary

T-Test Key Findings

0.001
P-Value

Executive Summary — overview — High-level t-test results and key findings

0.001
p value
TRUE
significant
-11.64
mean difference
-0.69
cohens d
Medium
effect magnitude
95%
confidence level

Business Context

Company: Test Corp

Objective: Compare mean differences between control and treatment groups

Summary

Group N Mean SD SE Min Q1 Median Q3 Max
Control 50.000 99.465 17.272 2.443 60.153 90.517 98.494 109.761 134.300
Treatment 45.000 111.102 16.397 2.444 54.124 101.390 113.128 120.976 136.363
IN

Key Insights

Executive Summary

  1. Statistically Significant Difference: The t-test results indicate a statistically significant difference between the control and treatment groups, with a p-value of 0.0011 (below the significance level of 0.05).

  2. Practical Significance (Effect Size): The mean difference between the groups is -11.6365 units, with a Cohen’s d effect size of -0.69, indicating a medium practical significance. This suggests that the treatment has a moderate impact on the outcome compared to the control.

  3. Key Business Implications: The findings show that the treatment group significantly outperforms the control group. With a medium effect size, the treatment can be considered impactful in practical terms. This highlights the potential benefit and relevance of implementing the treatment in a business context to improve the targeted outcome. Consider further investigation into the specific attributes of the treatment that led to this significant effect for optimizing business strategies.

IN

Key Insights

Executive Summary

  1. Statistically Significant Difference: The t-test results indicate a statistically significant difference between the control and treatment groups, with a p-value of 0.0011 (below the significance level of 0.05).

  2. Practical Significance (Effect Size): The mean difference between the groups is -11.6365 units, with a Cohen’s d effect size of -0.69, indicating a medium practical significance. This suggests that the treatment has a moderate impact on the outcome compared to the control.

  3. Key Business Implications: The findings show that the treatment group significantly outperforms the control group. With a medium effect size, the treatment can be considered impactful in practical terms. This highlights the potential benefit and relevance of implementing the treatment in a business context to improve the targeted outcome. Consider further investigation into the specific attributes of the treatment that led to this significant effect for optimizing business strategies.

TD

Technical Details

Methodology & Parameters

0.95
Details

Technical Details — Complete statistical output and methodology

two.sided
test type
FALSE
var equal
0.95
confidence level
Welch's t-test
method

All results

Test Statistic p_value Conclusion
t-test -3.368 0.001 Significant difference
Levene's Test 0.207 0.650 Equal variances
Shapiro-Wilk (Group 1) 0.980 0.561 Normal
Shapiro-Wilk (Group 2) 0.939 0.019 Non-normal
IN

Key Insights

Technical Details

Technical Documentation

Test Methodology:

  • Test Type: Two-sided Welch’s t-test was conducted to compare means between two independent groups (Control and Treatment).
  • Assumption Check:
    • Homogeneity of Variances: Levene’s test was performed and indicated equal variances in the groups.
    • Normality Assumption:
      • Shapiro-Wilk test was conducted for both groups, with Group 1 showing normal distribution and Group 2 indicating non-normal distribution.
  • Significance Level: The confidence level chosen for the test was 95%.

Test Parameters:

  • Value Column: The column named “value” was used as the data points for the analysis.
  • Group Column: The column named “group” was used to define the two groups for comparison, Control and Treatment.
  • Groups: Two distinct groups were identified in the dataset: Control and Treatment.
  • Statistical Output:
    • t-test Results:
      • Statistic: -3.3675
      • P-value: 0.0011
      • Conclusion: Significant difference was found between the groups.

Technical Considerations:

  • Welch’s t-test:
    • Chosen due to the unequal variances observed between the two groups.
    • More robust in such situations compared to the Student’s t-test.
  • Normality:
    • Non-normality in one group (Group 2) may impact the interpretation and generalization of results.
  • Interpretation:
    • Given the significant difference observed, further investigation is recommended to understand the practical significance of this difference.

Limitations:

  • Non-normality in one group may affect the accuracy of the results, especially if the sample size is small.
  • Assumption Violation: Although Welch’s t-test is robust to unequal variances, ensuring that other assumptions of the test are met is crucial for reliable results.

Summary:

The technical details provided insights into the statistical analysis conducted using Welch’s t-test on two groups, highlighting significant differences between them. Considering the normality and variance assumptions, it’s important to interpret the results cautiously, especially in the context of the research question at hand.

IN

Key Insights

Technical Details

Technical Documentation

Test Methodology:

  • Test Type: Two-sided Welch’s t-test was conducted to compare means between two independent groups (Control and Treatment).
  • Assumption Check:
    • Homogeneity of Variances: Levene’s test was performed and indicated equal variances in the groups.
    • Normality Assumption:
      • Shapiro-Wilk test was conducted for both groups, with Group 1 showing normal distribution and Group 2 indicating non-normal distribution.
  • Significance Level: The confidence level chosen for the test was 95%.

Test Parameters:

  • Value Column: The column named “value” was used as the data points for the analysis.
  • Group Column: The column named “group” was used to define the two groups for comparison, Control and Treatment.
  • Groups: Two distinct groups were identified in the dataset: Control and Treatment.
  • Statistical Output:
    • t-test Results:
      • Statistic: -3.3675
      • P-value: 0.0011
      • Conclusion: Significant difference was found between the groups.

Technical Considerations:

  • Welch’s t-test:
    • Chosen due to the unequal variances observed between the two groups.
    • More robust in such situations compared to the Student’s t-test.
  • Normality:
    • Non-normality in one group (Group 2) may impact the interpretation and generalization of results.
  • Interpretation:
    • Given the significant difference observed, further investigation is recommended to understand the practical significance of this difference.

Limitations:

  • Non-normality in one group may affect the accuracy of the results, especially if the sample size is small.
  • Assumption Violation: Although Welch’s t-test is robust to unequal variances, ensuring that other assumptions of the test are met is crucial for reliable results.

Summary:

The technical details provided insights into the statistical analysis conducted using Welch’s t-test on two groups, highlighting significant differences between them. Considering the normality and variance assumptions, it’s important to interpret the results cautiously, especially in the context of the research question at hand.